Related Experiment Video
Updated: Jun 6, 2026

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
Published on: May 24, 2016
Molecular physiology of cardiac regeneration
1Cardiovascular Regenerative Medicine, Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA.
Insights
Cardiac regeneration faces challenges due to cardiomyocyte immobility. Research explores enhancing the heart's natural repair mechanisms, offering future therapeutic potential for heart disease.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Heart disease remains a primary global mortality cause, largely due to the limited regenerative capacity of cardiomyocytes.
- Cardiac injury typically results in scar tissue formation rather than functional muscle repair.
Purpose of the Study:
- To review current therapeutic strategies for cardiac regeneration.
- To explore the potential of enhancing endogenous cardiac repair mechanisms.
Main Methods:
- Review of existing literature on stem cell therapies for myocardial infarction.
- Analysis of studies investigating the enhancement of intrinsic cardiac regenerative potential.
Main Results:
- Stem cell transplantation (bone marrow, cardiac, embryonic, induced pluripotent) has yielded ambiguous clinical outcomes for infarcted myocardium.
- Enhancing the heart's endogenous regenerative capacity presents a promising alternative approach.
Conclusions:
- While not yet clinically ready, advancements in regenerative biology suggest cardiac regeneration may become a viable therapeutic reality.
- Further research into endogenous repair mechanisms is crucial for future heart disease treatments.
Abstract:
Heart disease is the leading cause of death in the industrialized world. This is partially attributed to the inability of cardiomyocytes to divide in a significant manner, and therefore the heart responds to injury through scar formation. One of the challenges of modern medicine is to develop novel therapeutic strategies to facilitate regeneration of cardiac muscle in the diseased heart. Numerous methods have been studied and a wide variety of cell types have been considered. To date, bone marrow stem cells, endogenous populations of cardiac stem cells, embryonic stem cells, and induced pluripotent stem cells have been investigated for their ability to regenerate infarcted myocardium, although stem cell transplantation has produced ambiguous results in human clinical trials. Several studies support another approach that seems very appealing: enhancing the limited endogenous regenerative capacity of the heart. The recent advances in stem cell and regenerative biology are giving rise to the view that cardiac regeneration, although not quite ready for clinical treatment, may translate into therapeutic reality in the not too distant future.
Related Concept Videos
Pathophysiology of Heart Failure
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Pathophysiology of Cardiac Performance

